A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration
Clinical trial NCT05274516 · COMPLETED
Trial details
- NCT number
- NCT05274516
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2022-10-25
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.